糖尿病性足潰瘍治療市場- 世界の産業規模、シェア、動向、機会、予測、治療別、潰瘍タイプ別、エンドユーザー別、地域別セグメント、競合、2020年～2030年

糖尿病性足潰瘍治療の世界市場規模は2024年に55億1,000万米ドルで、予測期間中のCAGRは7.45%で2030年には84億8,000万米ドルに達すると予測されています。

糖尿病性足潰瘍治療の世界市場は、不健康な食習慣の消費とともに、座りっぱなしのライフスタイルを送る人が増えていることが背景にあり、大きな成長を遂げています。さらに、人々の美意識の高まりと相まって、無痛で低コストの治療に対する需要の高まりが、世界各地で糖尿病性足潰瘍治療の需要を大幅に高めています。さらに、足潰瘍のような様々な種類の潰瘍疾患に罹患しやすい高齢化人口が世界中で増加しているため、様々な歯科輪郭形成術の需要がさらに増加し、それによって市場の成長が促進されると予想されます。また、世界的に不健康なライフスタイルを送ることによる肥満の蔓延が拡大しており、予測期間中に糖尿病性足潰瘍治療市場をさらに下支えすると期待されています。

さらに、適切な医療機器や医薬品の使用が増加することで、糖尿病性足潰瘍治療の需要がさらに増加し、市場の成長を支えるものと予想されます。米国疾病予防管理センター（CDC）によると、米国では18歳以上の600万人が糖尿病予備軍であり、65歳以上の2,640万人（48.8%）が糖尿病予備軍です。

市場促進要因

世界の糖尿病有病率の上昇

主な市場課題

開発途上地域における高コストと償還制限

主要市場動向

遠隔医療と遠隔創傷モニタリングの統合

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 顧客の声

第5章 世界の糖尿病性足潰瘍治療市場展望

• 市場規模・予測
  • 金額別
• 市場シェア・予測
  • 治療別（創傷ケアドレッシング、生物学的製剤、治療機器、抗生物質、その他）
  • 潰瘍タイプ別（神経障害性潰瘍、虚血性潰瘍、神経虚血性潰瘍）
  • エンドユーザー別（病院・診療所、外来診療センター、その他）
  • 地域別
  • 企業別（2024）
• 市場マップ
  • 治療別
  • 潰瘍タイプ別
  • エンドユーザー別
  • 地域別

第6章 北米の糖尿病性足潰瘍治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 北米：国別分析
  • 米国
  • カナダ
  • メキシコ

第7章 欧州の糖尿病性足潰瘍治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 欧州：国別分析
  • フランス
  • ドイツ
  • 英国
  • イタリア
  • スペイン

第8章 アジア太平洋地域の糖尿病性足潰瘍治療市場展望

• 市場規模・予測
• 市場シェア・予測
• アジア太平洋地域：国別分析
  • 中国
  • インド
  • 日本
  • 韓国
  • オーストラリア

第9章 南米の糖尿病性足潰瘍治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第10章 中東・アフリカの糖尿病性足潰瘍治療市場展望

• 市場規模・予測
• 市場シェア・予測
• 中東・アフリカ：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第11章 市場力学

• 促進要因
• 課題

第12章 市場動向と発展

• 最近の動向
• 合併と買収
• 製品上市

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威/サービス

第14章 SWOT分析：世界の糖尿病性足潰瘍治療市場

第15章 競合情勢

• 3M Company
• Medtronic Plc
• ConvaTec, Inc.
• Coloplast Corporation
• Smith & Nephew Plc
• B Braun Melsungen AG
• Medline Industries, Inc.
• Organogenesis, Inc.
• Molnlycke Health Care AB
• Acelity L.P., Inc.

第16章 戦略的提言

第17章 調査会社について・免責事項

Global Diabetic Foot Ulcer Treatment Market was valued at USD 5.51 billion in 2024 and is expected to reach USD 8.48 billion by 2030 with a CAGR of 7.45% during the forecast period. The global market for Diabetic Foot Ulcer Treatment is experiencing significant growth, driven by the increasingly leading of sedentary lifestyle along with consuming unhealthy food habits. Additionally, the growing demand for painless treatment with low cost coupled with increasing aesthetic consciousness among the population has significantly increased the demand for diabetic foot ulcer treatment across different parts of the globe. Additionally, the growing aging population across the globe which is susceptible to different kinds of ulcer diseases like foot ulcers is further expected to increase the demand for different dental contouring procedures, thereby fuelling market growth. Besides, the growing prevalence of obesity because of leading unhealthy lifestyles across the globe is further expected to support the diabetic foot ulcer treatment market during the forecast period.

Furthermore, the growing usage of proper medical equipment and medicines is further expected to increase the demand for diabetic foot ulcer treatment, thereby supporting market growth. According to the Centers for Disease Control and Prevention (CDC), 6 million people aged 18 years or older have prediabetes in the United States and 26.4 million people aged 65 years or older (48.8%) have prediabetes.

Key Market Drivers

Rising Global Prevalence of Diabetes

One of the most significant drivers of the diabetic foot ulcer treatment market is the alarming rise in global diabetes prevalence. Diabetic foot ulcers are among the most serious complications of uncontrolled diabetes and often result in infection, hospitalization, or amputation if not properly managed. According to the International Diabetes Federation (IDF), approximately 537 million adults worldwide were living with diabetes in 2021-a figure projected to rise to 783 million by 2045. A significant proportion of these individuals are at risk of developing foot ulcers at some stage due to peripheral neuropathy and vascular complications.

In response, national healthcare systems are actively scaling up preventive treatment strategies for diabetic complications. For instance, the Centers for Disease Control and Prevention (CDC) in the U.S. estimates that 15% of diabetic patients develop foot ulcers, and up to 25% may eventually require amputation if untreated. Many countries, including India, China, and Brazil-where diabetes rates are surging-have launched national diabetes control programs focusing on early detection and comprehensive wound care.

The growing diabetic population has led to an increase in the demand for advanced wound care products, offloading devices, and surgical interventions. Government-supported reimbursements for chronic wound management in public health systems across Europe and North America also encourage greater access to treatment. As a result, the diabetic foot ulcer treatment market is experiencing continuous growth due to the expanding patient base and escalating need for long-term management solutions.

Key Market Challenges

High Cost and Limited Reimbursement in Developing Regions

One of the key challenges impeding the growth of the DFU treatment market is the high cost of advanced wound care solutions, particularly in low- and middle-income countries (LMICs). Treatments such as NPWT, skin grafts, bioengineered skin substitutes, and HBOT often require specialized equipment and trained personnel, making them unaffordable for many patients. Unlike high-income countries, where public health systems cover most costs, LMICs often lack comprehensive insurance schemes that include chronic wound care. According to the World Bank, more than half the world's population lacks access to essential healthcare services, and out-of-pocket healthcare expenses push approximately 100 million people into extreme poverty annually. This financial barrier makes it challenging for many diabetic patients to pursue prolonged ulcer care, leading to complications and avoidable amputations.

Key Market Trends

Integration of Telemedicine and Remote Wound Monitoring

With the digital transformation of healthcare, telemedicine is emerging as a vital trend in diabetic foot ulcer treatment. Patients with DFUs often require frequent assessments to monitor wound progression, detect signs of infection, and adjust treatment plans. In rural or underserved areas, access to wound care specialists is limited, making telehealth a critical tool for continuous care. Governments are increasingly recognizing the potential of digital health solutions. For example, the U.S. Health Resources and Services Administration (HRSA) and similar agencies in Europe have expanded funding for remote chronic care management tools, including wound imaging apps and digital platforms that allow clinicians to evaluate ulcers remotely. These technologies enable early detection of complications, improve patient compliance, and reduce the need for hospital visits.

In countries like Australia and Canada, telemedicine platforms are being used to connect patients in remote regions with urban wound care centers, ensuring equitable access to expertise. Some platforms use AI to assess wound size, depth, and tissue characteristics, supporting data-driven treatment decisions. Furthermore, digital recordkeeping and remote prescriptions simplify follow-ups and allow multidisciplinary teams to coordinate care more effectively. As global digital health adoption grows, integrating wound care into telemedicine ecosystems will be an important advancement in improving treatment outcomes and patient satisfaction for DFUs.

Key Market Players

• 3M Company
• Medtronic Plc
• ConvaTec, Inc.
• Coloplast Corporation
• Smith & Nephew Plc
• B Braun Melsungen AG
• Medline Industries, Inc.
• Organogenesis, Inc.
• Molnlycke Health Care AB
• Acelity L.P., Inc.

Report Scope:

In this report, the Global Diabetic Foot Ulcer Treatment Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diabetic Foot Ulcer Treatment Market, By Treatment:

• Wound Care Dressings
• Biologics
• Therapy Devices
• Antibiotic Medications
• Others

Diabetic Foot Ulcer Treatment Market, By Ulcer Type:

• Neuropathic Ulcers
• Ischemic Ulcers
• Neuroischemic Ulcers

Diabetic Foot Ulcer Treatment Market, By End User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Diabetic Foot Ulcer Treatment Market, By Region:

• North America
  • United States
  • Mexico
  • Canada
• Europe
  • France
  • Germany
  • United Kingdom
  • Italy
  • Spain
• Asia-Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Diabetic Foot Ulcer Treatment Market.

Available Customizations:

Global Diabetic Foot Ulcer Treatment Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diabetic Foot Ulcer Treatment Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Treatment (Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Others)
  • 5.2.2. By Ulcer Type (Neuropathic Ulcers, Ischemic Ulcers, Neuroischemic Ulcers)
  • 5.2.3. By End User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map
  • 5.3.1. By Treatment
  • 5.3.2. By Ulcer Type
  • 5.3.3. By End User
  • 5.3.4. By Region

6. North America Diabetic Foot Ulcer Treatment Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Treatment
  • 6.2.2. By Ulcer Type
  • 6.2.3. By End User
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Diabetic Foot Ulcer Treatment Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Treatment
      • 6.3.1.2.2. By Ulcer Type
      • 6.3.1.2.3. By End User
  • 6.3.2. Canada Diabetic Foot Ulcer Treatment Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Treatment
      • 6.3.2.2.2. By Ulcer Type
      • 6.3.2.2.3. By End User
  • 6.3.3. Mexico Diabetic Foot Ulcer Treatment Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Treatment
      • 6.3.3.2.2. By Ulcer Type
      • 6.3.3.2.3. By End User

7. Europe Diabetic Foot Ulcer Treatment Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Treatment
  • 7.2.2. By Ulcer Type
  • 7.2.3. By End User
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. France Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Treatment
      • 7.3.1.2.2. By Ulcer Type
      • 7.3.1.2.3. By End User
  • 7.3.2. Germany Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Treatment
      • 7.3.2.2.2. By Ulcer Type
      • 7.3.2.2.3. By End User
  • 7.3.3. United Kingdom Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Treatment
      • 7.3.3.2.2. By Ulcer Type
      • 7.3.3.2.3. By End User
  • 7.3.4. Italy Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Treatment
      • 7.3.4.2.2. By Ulcer Type
      • 7.3.4.2.3. By End User
  • 7.3.5. Spain Diabetic Foot Ulcer Treatment Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Treatment
      • 7.3.5.2.2. By Ulcer Type
      • 7.3.5.2.3. By End User

8. Asia-Pacific Diabetic Foot Ulcer Treatment Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Treatment
  • 8.2.2. By Ulcer Type
  • 8.2.3. By End User
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Treatment
      • 8.3.1.2.2. By Ulcer Type
      • 8.3.1.2.3. By End User
  • 8.3.2. India Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Treatment
      • 8.3.2.2.2. By Ulcer Type
      • 8.3.2.2.3. By End User
  • 8.3.3. Japan Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Treatment
      • 8.3.3.2.2. By Ulcer Type
      • 8.3.3.2.3. By End User
  • 8.3.4. South Korea Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Treatment
      • 8.3.4.2.2. By Ulcer Type
      • 8.3.4.2.3. By End User
  • 8.3.5. Australia Diabetic Foot Ulcer Treatment Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Treatment
      • 8.3.5.2.2. By Ulcer Type
      • 8.3.5.2.3. By End User

9. South America Diabetic Foot Ulcer Treatment Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Treatment
  • 9.2.2. By Ulcer Type
  • 9.2.3. By End User
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Diabetic Foot Ulcer Treatment Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Treatment
      • 9.3.1.2.2. By Ulcer Type
      • 9.3.1.2.3. By End User
  • 9.3.2. Argentina Diabetic Foot Ulcer Treatment Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Treatment
      • 9.3.2.2.2. By Ulcer Type
      • 9.3.2.2.3. By End User
  • 9.3.3. Colombia Diabetic Foot Ulcer Treatment Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Treatment
      • 9.3.3.2.2. By Ulcer Type
      • 9.3.3.2.3. By End User

10. Middle East and Africa Diabetic Foot Ulcer Treatment Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Treatment
  • 10.2.2. By Ulcer Type
  • 10.2.3. By End User
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Diabetic Foot Ulcer Treatment Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Treatment
      • 10.3.1.2.2. By Ulcer Type
      • 10.3.1.2.3. By End User
  • 10.3.2. Saudi Arabia Diabetic Foot Ulcer Treatment Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Treatment
      • 10.3.2.2.2. By Ulcer Type
      • 10.3.2.2.3. By End User
  • 10.3.3. UAE Diabetic Foot Ulcer Treatment Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Treatment
      • 10.3.3.2.2. By Ulcer Type
      • 10.3.3.2.3. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porters Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products/Services

14. SWOT Analysis: Global Diabetic Foot Ulcer Treatment Market

15. Competitive Landscape

• 15.1. 3M Company
  • 15.1.1. Business Overview
  • 15.1.2. Company Snapshot
  • 15.1.3. Products & Services
  • 15.1.4. Financials (As Reported)
  • 15.1.5. Recent Developments
  • 15.1.6. Key Personnel Details
  • 15.1.7. SWOT Analysis
• 15.2. Medtronic Plc
• 15.3. ConvaTec, Inc.
• 15.4. Coloplast Corporation
• 15.5. Smith & Nephew Plc
• 15.6. B Braun Melsungen AG
• 15.7. Medline Industries, Inc.
• 15.8. Organogenesis, Inc.
• 15.9. Molnlycke Health Care AB
• 15.10. Acelity L.P., Inc.

16. Strategic Recommendations

17. About Us & Disclaimer